GLG News by Contact Lens Sellers (US)

Mark Packer, Clinical Associate Professor of Ophthalmology

Mark PackerClinical Associate Professor of OphthalmologyOREGON HEALTH & SCIENCE UNIVERSITY - CC 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

FDA Panel votes for safety, effectiveness for the Glaukos iStent.

December 11, 2010

FDA Ophthalmic Device Panel Meeting, July 30, 2010 | www.fdalive.com

On July 30, 2010, the Ophthalmic Devices Panel reviewed data for the iStent, a trabecular micro-bypass shunt from Glaukos Corporation.  The Panel voted 7 – 1 that there is a reasonable assurance of safety, 6 – 2 that there is a reasonable assurance of effectiveness, and 7 – 1 that there is a favorable risk/benefit ratio. At the end of the day, it was the perspective of two glaucoma subspecialists sitting on the Panel, Eve Higginbotham and Anne Coleman, that carried the greatest weight. 

Steve Rubinstein, Optometrist

Steve RubinsteinOptometristSound Shore Vision Care 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

July 2010...B+L Voluntarily Recalls ReNu Multi-Purpose Solution

July 10, 2010

B+L Voluntarily Recalls Certain ReNu Multi-Purpose Solution and ReNu MultiPlus Multi-Purpose Solution in Europe and Middle East | www.visionmonday.com

No this is not 2007! A new problem has occurred in the manufacturing of Baucsh & Lomb's current signature contact lens disinfecting product, ReNu. Bausch has just released BioTrue, the next best product in Contact Lens care about 2 weeks ago.

Steve Rubinstein, Optometrist

Steve RubinsteinOptometristSound Shore Vision Care 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Abbott back in contact lens solution game

June 12, 2010

Abbott back in contact lens solution game | www.chicagobreakingbusiness.com

There are new regulations and new contact lens solutions being announced almost weekly. Both Abbott and Bausch & Lomb have released new information on contact lens solutions. The industry leader Alcon's OptiFree with almost 33% of the retail US market should announce a new solution soon.

Steve Rubinstein, Optometrist

Steve RubinsteinOptometristSound Shore Vision Care 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

New Contact Lens Products in the Pipeline From J&J (JNJ)

June 4, 2010

UPDATE 3-J&J sees fast-growing device market | www.reuters.com

At the 2nd qtr reports for Johnson & Johnson Vision (JNJ) products a new announcement for allergy sufferers can lead to a new vehicle for introduction of medications in the eye, and the whole body.

Mark Packer, Clinical Associate Professor of Ophthalmology

Mark PackerClinical Associate Professor of OphthalmologyOREGON HEALTH & SCIENCE UNIVERSITY - CC 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Femtosecond Lasers Come to Cataract Surgery

March 26, 2010

Femtosecond laser cataract surgery | bmctoday.net

Cataract surgeons are impelled by their inward drive towards perfection to love the possibilities that femtosecond phaco creates. This technology changes everything. The pioneers of phaco, and the surgical techniques they developed that are still in use today, are coming to appear as the devices of medieval artisans relative to the streamlined accuracy of a nascent industrial era. 

Mark Packer, Clinical Associate Professor of Ophthalmology

Mark PackerClinical Associate Professor of OphthalmologyOREGON HEALTH & SCIENCE UNIVERSITY - CC 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Digital 3D HD Imaging Gains Traction in the Ophthalmic OR

February 21, 2010

TrueVision Systems Releases First Ever 3D Visualization and Guidance Platform for Microsurgery | www.microscopy-news.com

There are tremendous applications for 3D HD surgery in ophthalmology, from education to archiving to enhancing surgical outcomes. As this technology moves forward through incision marking and toric intraocular lens placement with the Ophthalmic Tool Set, the capabilities of 3D surgery will surpass what we have in the standard microscope.

Steve Rubinstein, Optometrist

Steve RubinsteinOptometristSound Shore Vision Care 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Alcon Expanding Its Drug Offerings and Pipeline with 3 Medications

January 20, 2010

Alcon to purchase rights for two eye care products from Sirion Therapeutics | www.pharmabiz.com

The rights for the the new anti inflammatory medication Durezol is Hot. The rights for Zirgan is a much smaller market, but there is limited competition in that field.The New Dry Eye Syndrome medication for Ocular Surface Disease is the first potential since the blockbuster medication Restasis. This is undergoing clinical clinical testing now. There are one or two other Dry Eye Syndrome medications coming down the pipeline.

Steve Rubinstein, Optometrist

Steve RubinsteinOptometristSound Shore Vision Care 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Alcon would make a nice prize for Novartis

January 4, 2010

Top News Bloomberg Novartis May Sell Bonds in 2010 for $28.2 Billion Alcon Deal | www.businessweek.com

 It looks like Novartis AG is gearing up to purchase the rest of Alcon, Inc. 

Steve Rubinstein, Optometrist

Steve RubinsteinOptometristSound Shore Vision Care 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

What happens to the "Lifetime" guarantee?

December 21, 2009

TLC Vision, Tiger Woods Sponsor, Files for Bankruptcy | www.bloomberg.com

TLC Vision Corp (TLC),  The Laser Center, marketed their Lifetime touch up at no additional charge. What happens now that they have declared chapter 11 bankruptcy as of 12/21/2009?

Mark Packer, Clinical Associate Professor of Ophthalmology

Mark PackerClinical Associate Professor of OphthalmologyOREGON HEALTH & SCIENCE UNIVERSITY - CC 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Alcon Acquires Optonol

December 17, 2009

Optonol: Reaping $180m from a device the size of a grain of rice | www.haaretz.com

Alcon, the U.S. eye care pharmaceuticals and devices giant, announced this week that it will acquire Optonol, an Israeli company that manufactures the Ex-PRESS glaucoma mini-shunt. This innovative shunt has demonstrated good results in the reduction of intraocular pressure, with investigators reporting about 95% success at 3 years (http://community.modernmedicine.com/_Growing-Glaucoma-ProceduresECP-and-the-Ex-PRESS-Shunt/blog/439235/33379.html). 

Page : 12345678Next1 to 10 of 71

Leading institutions connect with members of the Healthcare councils through GLG